Short Interest in Innovator IBD 50 ETF (NYSEARCA:FFTY) Expands By 169.8%

Innovator IBD 50 ETF (NYSEARCA:FFTY) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 31,675 shares, an increase of 169.8% from the August 15th total of 11,741 shares. Approximately 1.5% of the company’s shares are short sold. Based on an average daily volume of 17,743 shares, the days-to-cover ratio is presently 1.8 days.

Innovator IBD 50 ETF Trading Down 1.0%

Innovator IBD 50 ETF stock traded down $0.36 during trading hours on Monday, hitting $34.88. 4,602 shares of the stock traded hands, compared to its average volume of 56,390. Innovator IBD 50 ETF has a one year low of $31.61 and a one year high of $44.08. The company has a market cap of $74.99 million, a PE ratio of 30.34 and a beta of 1.45. The firm’s 50-day moving average price is $37.51 and its two-hundred day moving average price is $38.30.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Institutional investors and hedge funds have recently made changes to their positions in the business. Guardian Wealth Advisors LLC NC bought a new position in Innovator IBD 50 ETF during the 2nd quarter valued at approximately $507,000. Kraematon Investment Advisors Inc. purchased a new position in Innovator IBD 50 ETF in the second quarter worth about $1,021,000. Concurrent Investment Advisors LLC increased its position in shares of Innovator IBD 50 ETF by 11.1% during the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after acquiring an additional 6,321 shares in the last quarter. KFG Wealth Management LLC purchased a new position in Innovator IBD 50 ETF in the 2nd quarter worth approximately $201,000. Finally, WorthPointe LLC lifted its position in Innovator IBD 50 ETF by 18.3% in the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after acquiring an additional 3,771 shares in the last quarter.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.